抗血栓药和溶血栓药的临床应用 的 Arg561-Val562 肽链,使单链无活性的 PLG 转化为双链有活性的 PL 。 2. 尿激酶型纤溶酶原激活剂( urokinase type PA,u-PA ) 主要由泌尿系统上皮细胞合成。呈单链形成存在者称单链 u-PA ( single chain u
基于14个网页-相关网页
U PA 纤溶酶原激活物 ; 酶原激活物
nipphannar u pa 完成色
u erthed pa enger 统舱旅客无铺位旅客 ; 没有铺位旅客
u erth pa enger 统舱旅客
PA-U 个人接纳
pari pa u 按相同比例
Kon-Chog U-Phang Nyen-Po Toe-Pa-Dhang 祈依尔誓弘扬三胜宝
Objective: to investigate the clinical effectiveness of prolonged low-dose urine plasminogen activator (u-PA) therapy in patients with unstable angina pectoris (UAP).
目的:观察小剂量长疗程尿纤溶酶原激活物(u - PA)治疗不稳定型心绞痛(uap)的临床疗效。
Methods Immunocytochemical staining was used to study the biologic markers of disseminated tumor cells, and U-PA activity of the plasma in the bone marrow was assayed in breast cancer patients.
方法采用免疫组化染色检测乳腺癌患者骨髓中肿瘤细胞的生物学标志及骨髓血浆的u PA活性。
Pa. ), who then proceeded to lambaste Toyota for failing to act sooner to deal with safety problems and threw in a plug for the U. S. product-liability system.
随后他痛责丰田公司未能更快采取行动应对安全问题,并妨碍了美国的产品可靠性体系。
应用推荐